MiniStudio is a Paris-based AI banner that rolled out in 2024 with just one IP, 'Fuzzlets' which has quietly become a ...
Exelixis has taken a $20 million option to license in an antibody-drug conjugate cancer (ADC) drug from Iconic, with clinical trials expected to start next year. The California biotech had reached an ...